These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 29440226)

  • 1. A single nucleotide incorporation step limits human telomerase repeat addition activity.
    Chen Y; Podlevsky JD; Logeswaran D; Chen JJ
    EMBO J; 2018 Mar; 37(6):. PubMed ID: 29440226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Requirements for the dGTP-dependent repeat addition processivity of recombinant Tetrahymena telomerase.
    Hardy CD; Schultz CS; Collins K
    J Biol Chem; 2001 Feb; 276(7):4863-71. PubMed ID: 11096070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A self-regulating template in human telomerase.
    Brown AF; Podlevsky JD; Qi X; Chen Y; Xie M; Chen JJ
    Proc Natl Acad Sci U S A; 2014 Aug; 111(31):11311-6. PubMed ID: 24982163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. dGTP-dependent processivity and possible template switching of euplotes telomerase.
    Hammond PW; Cech TR
    Nucleic Acids Res; 1997 Sep; 25(18):3698-704. PubMed ID: 9278493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How DNA damage and non-canonical nucleotides alter the telomerase catalytic cycle.
    Sanford SL; Welfer GA; Freudenthal BD; Opresko PL
    DNA Repair (Amst); 2021 Nov; 107():103198. PubMed ID: 34371388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yeast telomerase is capable of limited repeat addition processivity.
    Bosoy D; Lue NF
    Nucleic Acids Res; 2004; 32(1):93-101. PubMed ID: 14704347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human telomerase inhibition by 7-deaza-2'-deoxypurine nucleoside triphosphates.
    Fletcher TM; Salazar M; Chen SF
    Biochemistry; 1996 Dec; 35(49):15611-7. PubMed ID: 8961922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of telomerase inhibition by oxidized and therapeutic dNTPs.
    Sanford SL; Welfer GA; Freudenthal BD; Opresko PL
    Nat Commun; 2020 Oct; 11(1):5288. PubMed ID: 33082336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of 5' template usage and incorporation of noncognate nucleotides by human telomerase.
    Moriarty TJ; Marie-Egyptienne DT; Autexier C
    RNA; 2005 Sep; 11(9):1448-60. PubMed ID: 16120835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of dGTP concentration on human and CHO telomerase.
    Maine IP; Chen SF; Windle B
    Biochemistry; 1999 Nov; 38(46):15325-32. PubMed ID: 10563818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA-binding determinants and cellular thresholds for human telomerase repeat addition processivity.
    Wu RA; Tam J; Collins K
    EMBO J; 2017 Jul; 36(13):1908-1927. PubMed ID: 28495680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of nucleotide analogues on Euplotes aediculatus telomerase processivity: evidence for product-assisted translocation.
    Jarstfer MB; Cech TR
    Biochemistry; 2002 Jan; 41(1):151-61. PubMed ID: 11772012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A possible mechanism of processive nucleotide and repeat additions by the telomerase.
    Xie P
    Biosystems; 2009 Sep; 97(3):168-78. PubMed ID: 19580845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A modified model for translocation events of processive nucleotide and repeat additions by the recombinant telomerase.
    Xie P
    Biophys Chem; 2010 Dec; 153(1):83-96. PubMed ID: 21055868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-time detection of human telomerase DNA synthesis by multiplexed single-molecule FRET.
    Hentschel J; Badstübner M; Choi J; Bagshaw CR; Lapointe CP; Wang J; Jansson LI; Puglisi JD; Stone MD
    Biophys J; 2023 Sep; 122(17):3447-3457. PubMed ID: 37515327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants in mammalian telomerase RNA that mediate enzyme processivity and cross-species incompatibility.
    Chen JL; Greider CW
    EMBO J; 2003 Jan; 22(2):304-14. PubMed ID: 12514136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An anchor site-type defect in human telomerase that disrupts telomere length maintenance and cellular immortalization.
    Moriarty TJ; Ward RJ; Taboski MA; Autexier C
    Mol Biol Cell; 2005 Jul; 16(7):3152-61. PubMed ID: 15857955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Processivity of Telomerase: Insights from Kinetic Simulations and Analyses.
    Bagshaw CR; Hentschel J; Stone MD
    Molecules; 2021 Dec; 26(24):. PubMed ID: 34946615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA/DNA hybrid binding affinity determines telomerase template-translocation efficiency.
    Qi X; Xie M; Brown AF; Bley CJ; Podlevsky JD; Chen JJ
    EMBO J; 2012 Jan; 31(1):150-61. PubMed ID: 21989387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of human telomerase activity and function by two color single molecule coincidence fluorescence spectroscopy.
    Ren X; Li H; Clarke RW; Alves DA; Ying L; Klenerman D; Balasubramanian S
    J Am Chem Soc; 2006 Apr; 128(15):4992-5000. PubMed ID: 16608333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.